Empower Your Fight Against Breast Cancer
Breast cancer treatment is highly dependent on precise molecular subtyping. Find out why safely banking your tumor tissue ensures access to evolving hormonal and targeted therapies should the disease recur.
Talk to a Care SpecialistWhat is Breast Cancer?
Breast cancer is an uncontrolled growth of cells lining the breast ducts or lobules. It is not a single disease, but rather a collection of biologically distinct subtypes driven by different hormones and proteins.
Treatments range from highly effective hormone-blocking pills for ER-positive tumors, to aggressive systemic combinations for Triple-Negative cases that lack standard target receptors.
What Does Breast Cancer Do?
Tumors locally invade breast and lymphatic tissue before accessing the general circulation.
- Lymphatic Spread: Cancer cells rapidly migrate to axillary (underarm) lymph nodes, gaining transit throughout the body.
- Bone and Organ Metastasis: Advanced stages frequently target bones, liver, and lungs, compromising structural and systemic health.
- Hormonal Disruption: The cancer's interaction with estrogen and progesterone deeply intertwines with the body's endocrine system.
Current Treatment Options
Lumpectomy or Mastectomy
The foundational step of physically removing the tumor, wide margins, and potentially examining sentinel lymph nodes.
Endocrine (Hormone) Therapy
For hormone-receptor-positive cancers, long-term medications block hormones from fueling remaining microscopic cells.
HER2-Targeted Regimens
Specific monoclonal antibodies (like Herceptin) deployed strictly against tumors expressing excess HER2 proteins.
Why Bank Your Living Breast Tissue?
Particularly in Triple-Negative or highly recurrent Breast Cancer, standard therapies frequently hit a ceiling. Having your tumor cultivated alive allows scientists to hunt for off-label targets and screen developmental antibody-drug conjugates directly on your tissue.
Organoid Culturing
Build a perfect 3D replica of your breast tumor to empirical test sensitivity to varying chemotherapy cocktails.
Re-Evaluating Receptor Status
Breast cancers can change receptor statuses upon recurrence. Having original baseline living tissue allows critical comparative analysis.
Antibody-Drug Conjugate Testing
Evaluate if the newest smart-bomb chemotherapies effectively latch onto and destroy your specific cellular subtype.
Trial Preservation
Guarantee your eligibility for rapid enrollment in clinical trials investigating novel hormone disruptors and immunotherapies.